Strategic Partnerships AUM Biosciences has formed strategic partnerships with major players like Everlife Asia Pte. Ltd., Handok Inc., and SPRIM Health Group, indicating potential collaboration opportunities or avenues for cross-selling within these networks.

Awards & Recognition AUM Biosciences was recognized as the 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year by Frost & Sullivan. Leveraging this award can be a valuable talking point to establish credibility and differentiate the company in sales pitches.

Series A Funding With a successful $27 million Series A funding round, AUM Biosciences demonstrates strong investor confidence. This financial backing could be highlighted to showcase stability and investment potential to attract new partners or clients.

Precision Oncology Focus AUM Biosciences is dedicated to advancing precision oncology therapeutics to combat cancer resistance. This focus presents sales opportunities for pharmaceutical companies seeking innovative solutions in oncology treatments or research.

Market Presence Operating from Singapore, AUM Biosciences occupies a strategic position in the Asia-Pacific biotech market. Leveraging this regional presence, the company can target local and regional partners interested in expanding or establishing a foothold in the area.